Calidi Biotherapeutics, Inc 10-K for FY2023
Calidi Biotherapeutics, Inc. (CLDI)
10-K
2024-03-15
For: 2023-12-31
View Original
Added on
April 12, 2026
About this 10-K
Calidi Biotherapeutics, Inc filed this 10-K on March 15, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $29.22M
- compared with a net loss of $25.43M a year earlier
- Diluted EPS
- $1.73
- down 42.1% from $2.99 a year earlier